Labelling 101: A Comprehensive Overview for Medical Device Manufacturers

Kamiya Crabtree
A label maker printing bar-code labels.

Labelling is a crucial aspect of medical device compliance, ensuring that essential information is effectively communicated to users. Labelling includes written, printed, or graphic details on the device itself, its packaging, or accompanying materials such as Instructions for Use (IFU). Regulatory bodies require manufacturers to provide clear and accurate labelling to enhance patient safety, facilitate proper usage, and comply with international standards.

Medical Device Labelling Standard: ISO 15223-1:2021

ISO 15223-1 sets out requirements for symbols used in medical device labelling to communicate information about the safe and effective use of devices. The latest version, ISO 15223-1:2021, includes additional symbols to comply with the requirements of EU MDR 2017/745.

According to the ISO 15223-1 standard, medical device labelling symbols are organised into seven categories:

  • Manufacturing: Symbols related to the manufacturing process of the device.
  • Storage: Symbols indicating specific storage conditions for the device.
  • Safe use: Symbols providing information on the safe and proper use of the device.
  • Sterility: Symbols indicating the sterile condition of the device or instructions related to sterility.
  • IVD specific: Symbols specific to in vitro diagnostic devices.
  • Transfusion/Infusion: Symbols related to transfusion or infusion procedures.
  • Others: Symbols that do not fall into the above categories but are still relevant to medical device labelling.

Standardised symbols help manufacturers effectively communicate vital information to users, enhancing safety and reducing risks of errors or misinterpretation.

Regulatory requirements mandate that devices must be clearly identifiable as medical devices. The medical device symbol, in accordance with ISO 15223, can be displayed on the label to facilitate recognition and ensure regulatory compliance.

Medical Device logo.

Additionally, manufacturers must adhere to labelling regulations outlined in GSPR 23.1(a) and GSPR 20.1(a). These guidelines specify that certain label information must also be included in the Instructions for Use (IFU), and any symbols used on the label may require an explanation within the IFU.

Substances Specific Information

The label must also specify if the device contains or incorporates any of the following substances:

Does the device contain specific substances? decision diagram.

Label Marking Requirements (ISO 20417:2021)

ISO 20417:2021 defines a label as “written, printed, or graphic information appearing on the item itself, on the packaging of each item, or on the packaging of multiple items.” According to this standard, manufacturers must ensure that the device is marked with the relevant information, unless:

  • The size of the device does not allow for fixation of the information.
  • The nature of the outer surface of the device does not allow for the information to be fixed.
  • The omission of the markings does not negatively affect the benefit-risk balance as per ISO 14971:2019.

Packaging and Sterility Requirements

Packaging plays an essential role in ensuring that medical devices remain protected during transport, storage, and handling. ISO 11607 specifies requirements for the development and validation of processes for packaging medical devices. Compliance with ISO 11607 helps demonstrate conformity with essential requirements. Similar to the FDA, the EU requires compliance with ISO 10993-1 for the biological evaluation of medical device packaging materials.

EU MDR 2017/745 annex I GSPR, specifies the packaging requirements of medical devices. The requirements can be summarised as;

  • The packaging must protect the device and maintain its integrity, ensuring it remains sterile if applicable.
  • Non-sterile devices must be packaged in a way that maintains their cleanliness and integrity.
  • The packaging must be designed to minimise contamination risks during transportation and storage.

For sterile devices, the packaging must ensure the device remains sterile until the packaging is opened.

  • The sterile packaging of a device should include the following information:
  • An indication to recognise the packaging as sterile.
  • A declaration that the device is in a sterile condition.
  • The method of sterilisation.
  • Instruction to check the instructions for use on what to do if the sterile packaging is damaged or unintentionally opened before use.

Checklist for EU MDR Medical Device Labelling

Avoid compliance pitfalls with this checklist of essential labelling requirements for medical devices:

Key Requirement Yes/No
Product name  
Product’s lot number or serial number  
All details needed for a user to identify the device, the contents of its packaging and the intended purpose of the device  
Contact details of the manufacturer (e.g., name and address)  
In the case of non-EU-based manufacturers, the name and address of their authorised representative  
Where relevant, information per Section 10.4.5. of the MDR  
The UDI carrier referred to in Part C of Annex VII of the MDR  
An indication of any special storage or handling conditions  
A clear indication of the time limit for using the device safely, or where this is not applicable – the date of manufacture  
If the product is supplied in a sterile condition, an indication of its sterile state and method of sterilisation  
An indication if the product is for single-use  
An indication if the device is custom-made or intended for clinical investigation only  
Other warnings and precautions to be taken that need to be brought to the user’s immediate attention  

Why is medical device labelling so important?

For medical devices to be used safely and effectively, it is crucial that patients, caregivers, and healthcare providers receive clear and concise instructions, guidance, and warnings. Failure to follow these instructions, or mishandling the device, can result in malfunction, injury, or even death. While some mistakes may cause severe harm, even minor errors can impact patient outcomes in significant ways.

The well-being of the user must always be the primary concern for those involved in the manufacturing and design of medical devices. Effective labelling is essential in preventing misuse and ensuring proper usage. Moreover, complying with labelling standards isn’t just about safety—it also helps manufacturers meet regulatory requirements, avoiding costly delays, recalls, or legal issues.

The Final Stamp of Approval on Labelling

Labelling and packaging are critical aspects of medical device regulation, ensuring both compliance with the EU MDR and safety for patients and users. Medical device manufacturers must adhere to the extensive labelling requirements, including clear information on the device’s identity, use, storage, and associated risks. Failure to comply with these requirements can lead to regulatory challenges and safety concerns. By adhering to the EU MDR labelling and packaging guidelines, manufacturers can ensure their devices are compliant, safe, and ready for market entry.

Need expert guidance on medical device labeling? Mantra Systems is here to help. Our tailored solutions ensure your devices meet all regulatory requirements while streamlining compliance processes. Reach out today for tailored solutions!

Related articles

  1. A man carefully steps across a cliff-face. An analogy for assessing risk.

    Top 5 Common Pitfalls to Avoid During Risk Assessment

    Learn how to sidestep costly mistakes which manufacturers commonly make. From hazard ID to post-market surveillance, we help you improve safety and speed up approvals.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  2. An illustration of a brain-shaped object on an abstract background.

    European Commission Guidelines on Prohibited Artificial Intelligence Practices

    Summary of the 8 AI practices prohibited by the EU 2024/1689 artificial intelligence (AI) Act.

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  3. A compass being used to navigate across mountainous countryside.

    Navigating Non-Conformities in Technical Documentation

    We explore how to manage non-conformities effectively and implement Corrective and Preventive Actions (CAPAs).

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  4. A photograph of a literal maze that we're using as a clever metaphor.

    Mastering the EU MDR: Essential Steps for Compliance-Ready Docs

    If you're uncertain about the readiness of your EU MDR documentation, this article provides an overview of the essential steps to ensure you’re on track.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  5. An illustration showing scientists at work.

    A Guide to Electronic Instructions for Use (eIFU)

    Electronic Instructions for Use (eIFUs) are set to revolutionise how medical device instructions are delivered. We explore what this means for you.

    Dr Will Brambley Dr Will Brambley Lead Medical Writer
  6. Two helicopters look as if they are about to collide: An analogy for risk.

    Navigating Risk Management Requirements under the EU MDR

    This is a cornerstone of EU MDR 2017/745, requiring a continuous, well-documented approach. We unpack key requirements and provide actionable strategies.

    Peter Boxall Peter Boxall Lead Medical Writer
  7. A doctor operates a tablet computer.

    Beyond the Acronyms: Understanding SaMD and SiMD

    As software advancements continue, the line between traditional hardware-centric medical devices and software-driven solutions becomes increasingly blurred.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  8. A team of profesional-looking people sit around a table, congratulating themselves.

    Extending the Validity of your IVDD Certificates – Key Dates

    The EU and the MHRA have extended the validity of IVDD certificates, allowing you more time to transition to the IVDR. We explain what this means for manufacturers.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  9. A team of profesional-looking people sit around a table, congratulating themselves.

    GSPR 1: A New Era of Performance with Safety at the Core

    This regulation emphasizes risk management, durable design & biocompatibility to ensure medical devices are safe and effective. GSPR 1 protects users while driving innovation in medical technology.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  10. Cybersecurity Vulnerabilities in Medical Devices: FDA Alerts on Contec and Epsimed Monitors

    Patients can be exposed to risks when devices are online. We explore implications for EU MDR/IVDR cybersecurity requirements, including MDCG guidance

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  11. A futuristic-looking factory full of labelled cardboard boxes.

    Decoding UDI: Your Ultimate Guide to Smarter Medical Device Labelling

    The Unique Device Identifier (UDI) ensures medical device traceability and compliance. We break down its structure, Device Identifier (UDI-DI), Production Identifier (UDI-PI) and its role in EUDAMED.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  12. A medical team discuss performance data at their desktop computer.

    Key Updates for Navigating EMDN: MDCG 2024-2 Rev.1 & 2021-12 Rev.1

    Release of the updated guidance helps manufacturers navigate the EMDN system for accurate device classification, ensuring market access.

    Ron Sangal Ron Sangal Lead Medical Writer
  13. A dated monitor for medical equipment.

    Understanding Clinical Evidence Requirements with MDCG 2020-6

    How can manufacturers ensure legacy devices meet MDR's stringent requirements? Discover how MDCG 2020-6 guidance simplifies the path to compliance.

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  14. A stethoscope laid on a desk of regulatory documentation.

    Clinical benefits of an in vitro diagnostic medical device

    How to determine the clinical benefit of an IVD and successfully incorporate it into regulatory documentation.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  15. EU flags

    Regulation (EU) 2024/1860 - Its impact on EU MDR and IVDR

    How does the recent Regulation (EU) 2024/1860 amendment affect the EU MDR & IVDR?

    Shona Richardson Shona Richardson Regulatory Medical Writer
  16. EU flag

    MDCG 2024-10 - Orphan medical devices

    How to apply MDR pre-market clinical evidence requirements to medical devices intended for limited usage.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  17. Considering a medical device's intended purpose

    A medical device's intended purpose - what is the point?

    How do you define intended purpose, indication for use, intended clinical benefits, and claims?

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  18. Mantra Systems presents EnableChat, your AI-powered MDR & MDCG chatbot

    EnableChat - Your AI-powered MDR and MDCG chatbot

    Search the MDR and MDCG documents in seconds by asking EnableChat your questions.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  19. Searching adverse event databases for vigilance data

    Staying vigilant - A guide to searching for adverse events data

    We discuss the pros and cons of existing adverse event databases for vigilance data searching.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  20. A doctor reading an SSCP document with a patient

    What is Summary of Safety and Clinical Performance (SSCP)?

    We explain what the SSCP is, when you'll need it and what its objectives are.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  21. A pile of question marks

    Medical Device 'Significant Changes' – Navigating EU MDR Article 120(3) using MDCG 2020-3 rev. 1

    Understand what changes to your medical device are considered 'significant' under EU MDR (2017/745).

    Shen May Khoo Shen May Khoo Junior Regulatory Specialist
  22. A signpost giving unsure directions

    MDR or IVDR - A sibling rivalry?

    A guide to easily understanding whether your device is a medical device or an in vitro diagnostic medical device (IVD).

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  23. An EU and UK flag

    What the latest Brexit U-turn means for CE Marking of medical devices in Great Britain

    Will Great Britain continue to allow the use of the CE mark for medical devices beyond the 2024 deadline?

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  24. A woman writing her own medical device regulation documentation

    Gain confidence, reassurance and control over your EU MDR strategy

    Find out how to build your own technical files within a guided framework while minimising financial outlays.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  25. Racing to achieve MDR compliance

    Still racing to achieve MDR compliance? A transition period update

    On January 6th 2023, the EU commission has adopted the proposal to extend the transition rules of the EU MDR.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  26. A 7-step guide to navigating regulatory requirements for medical device start-ups

    A medical device regulations guide for start-up companies

    We present a 7-step guide to navigating regulatory requirements on a budget.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  27. An update on UKCA Marking of Medical Devices

    UKCA Marking of Medical Devices – An update on the status quo

    We review recently updated requirements for UKCA marking and what it means for your regulatory strategy.

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  28. How to choose a CER writer for your MDR Clinical Evaluation

    Choosing a CER writer for your MDR Clinical Evaluations

    We've compiled a list of considerations that will help you make the right choice when choosing a CER writer.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  29. Achieving MDR Compliance for Class I medical devices

    How to achieve MDR Compliance for Class I medical devices

    We outline a strategy for the regulatory compliance of Class I medical devices.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  30. Literature Search, SOTA Review and Clinical Evaluation

    Literature Search, SOTA Review process and Clinical Evaluation

    We help to demystify the process of systematic search & review of literature for Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  31. Literature Search Protocols & SOTA Reviews for medical devices and what to know before you start

    Literature searches and reviews for medical devices - what to know before you start

    We explain what you should know before beginning a literature search & review for your medical device.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  32. Five useful resources when writing a medical device CER

    Five useful resources when writing a medical device CER

    We outline five of the most useful and trustworthy Clinical Evaluation Report writing resources.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  33. Avoid pitfalls when writing a Clinical Evaluation Report

    Five common pitfalls when writing a Clinical Evaluation Report

    We illustrate five pitfalls when writing CERs and give you some tips to overcome them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  34. How to make a medical device equivalence claim under the MDR

    Five tips for making a medical device equivalence claim under the MDR

    We'll show you what to keep in mind with regards to equivalance and Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  35. Keeping medical devices in market and maintaining CE-marks - a guide to effective data collection

    Keeping medical devices in market and maintaining CE-marks

    The 4 golden rules to drive regulatory compliance with PMCF and vigilance data collection.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  36. How PMCF goes beyond simple compliance - improving products and engaging customers

    How PMCF goes beyond simple compliance

    The wider benefits of a well-designed PMCF system include improving your products and your relationship with your clients.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  37. PMCF systems for medical devices

    Why you'll almost certainly need a PMCF system for your medical devices

    We tell you what to be aware of under the EU MDR regarding PMCF and your medical devices.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  38. Ensure medical device regulatory compliance of your devices through Brexit

    The impact of Brexit on medical device regulatory compliance

    How to ensure regulatory alignment of your devices in the territories affected by Brexit.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  39. Use medical device regulatory consulting services to supercharge your MDR transition

    Is outside consulting support the answer to your MDR transition?

    Getting ready for the MDR is a demanding process. Outsourcing might be your solution.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  40. Increasing data entry compliance in PMCF studies

    Increasing data entry compliance in PMCF studies

    5 methods every medical device manufacturer should know to improve their Post-Market Clinical Follow-up studies.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  41. Why medical doctors can drive MDR compliance

    Why medical doctors can drive MDR compliance

    Working with the MDR requires knowing how to work with clinical evidence. Medical doctors are perfectly positioned to meet this requirement.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  42. Software as a Medical Device

    Software as a Medical Device

    Unless you have spent time working with medical device legislation in the past, the idea that software could be a medical device may be rather unexpected.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  43. clinical investigator for pmcf eu mdr compliance

    Ensuring that clinical investigations work in practice

    How can medical device manufacturers ensure valid clinical investigations when access to medical expertise remains limited?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  44. Coronavirus and medical device regulations

    Relaxing medical device regulatory requirements during a healthcare crisis

    During the coronavirus pandemic, how far should we go when relaxing medical device regulatory requirements?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  45. The new MDR compliance challenge

    The new MDR compliance challenge

    Across the industry, medical device companies are facing challenges in meeting the demands of the new Medical Device Regulations (MDR) 2017/745 framework.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  46. Sources of Real World Evidence for MDR compliance

    Sources of Real World Evidence for MDR compliance

    At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need support with your medical device approval strategy?

Contact us today